Files in This Item:
   
Thumbnail11_5-6_2005_1003_1008.pdf

View/Open

Title: Acetylator phenotype in Iraqi patients with systemic lupus erythematosus
Authors: Najim, R.A.
Farid, Y.Y.
Samad, T.A.
Shihab, S.A.
Issue Date: 2005
Language: English
Abstract: The study was designed to determine the acetylator status in patients with systemic lupus erythematosus [SLE] and compare it to a matched group of healthy volunteers. Disease severity was determined using the revised American College of Rheumatology criteria for classification and the SLE disease activity index. After an overnight fast, each participant received a single oral dose of 100 mg dapsone. After 3 hours, plasma dapsone/monoacetyldapsone ratio was determined. In the control group, frequency of slow acetylators was 73.3%; frequency of rapid acetylators was 26.7%. In SLE patients, frequency of slow acetylators was 78.0%; frequency of rapid acetylators was 12.0%. However, 8.0% were non-acetylators [monoacetyldapsone not detected in plasma]. There was no association between acetylator status and severity of SLE
Description: 1003-1008
Keywords: Acetylation
Administration, Oral
Adolescent
Adult
Biotransformation
Case-Control Studies
Subject: Dapsone
URI: http://www.who.int/iris/handle/10665/117032
ISSN: 1020-3397
Other Identifiers: http://applications.emro.who.int/emhj/1105_6/11_5-6_2005_1003_1008.pdf
Appears in Collections:EMRO Journal Articles (EMHJ)



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.